Health Business

Unichem Laboratories completes sale and transfer of its domestic formulations business to Torrent Pharmaceuticals

Unichem Laboratories Limited (“Unichem”) has completed the sale and transfer of its domestic formulations business in India and Nepal, on a going concern basis by way of slump sale, to Torrent Pharmaceuticals Limited (TPL).

Left-to-Right-Jayendra-Shah,-Sr-Partner,-N.A-Shah-Associates-LLP,-Sudhir-Mehta,-Chairman-Emeritus,-Torrent-Pharmaceuticals-and-Prakash-Mody,-CMD,-Unichem-Laboratories-Ltd

Going ahead Unichem will:

  • focus attention on all aspects of the international business including finished formulations, API, contract manufacturing and contract research;
  • increase its investments in R&D in the New Chemical and Biological Entities (NCE & NBE), Bio-similars and complex generics; and
  • reward shareholders

Mr. Jayendra Shah, played a pivotal role in successful consummation of the transaction. He was the sole financial advisor to Unichem on negotiations, valuations and deal closure. N A Shah Associates LLP, Chartered Accountants were the advisors for tax and related matters and Trans Continental Capital Advisors Pvt. Ltd. were the strategic advisors.

Don't be shellfish...Share on Facebook0Share on Google+0Share on LinkedIn0Share on StumbleUpon0Pin on Pinterest0Tweet about this on Twitter0
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

To Top